Does MEGLUMINE Cause Therapy non-responder? 24 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Therapy non-responder have been filed in association with MEGLUMINE. This represents 4.1% of all adverse event reports for MEGLUMINE.
24
Reports of Therapy non-responder with MEGLUMINE
4.1%
of all MEGLUMINE reports
23
Deaths
24
Hospitalizations
How Dangerous Is Therapy non-responder From MEGLUMINE?
Of the 24 reports, 23 (95.8%) resulted in death, 24 (100.0%) required hospitalization, and 24 (100.0%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGLUMINE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does MEGLUMINE Cause?
Off label use (389)
Maternal exposure during pregnancy (300)
Joint swelling (294)
Pemphigus (289)
Glossodynia (288)
Inflammation (285)
Pain (284)
General physical health deterioration (283)
Folliculitis (282)
Hypertension (282)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which MEGLUMINE Alternatives Have Lower Therapy non-responder Risk?
MEGLUMINE vs MELATONIN
MEGLUMINE vs MELOXICAM
MEGLUMINE vs MELPERONE
MEGLUMINE vs MELPHALAN
MEGLUMINE vs MEMANTINE